Top Story

Combination of trastuzumab, XELOX shows promise for advanced gastric cancer

February 27, 2015

The addition of trastuzumab to the standard first-line regimen of capecitabine plus oxaliplatin created a highly effective and well-tolerated combination for the treatment of advanced gastric cancer, according to results of a phase 2 study.

Advancements in the understanding of gastric cancer biology have led to targeted therapies focused on HER-2.

In the Journals

Chest CT imaging may safely be omitted from neuroblastoma surveillance for pediatric patients

February 27, 2015
Neuroblastoma progression or recurrence in the chest is rare among children and usually can be detected with non-CT imaging modalities or through the presentation of…
In the Journals

Reconstruction for pelvic tumors achieves satisfactory survival, increases complication rates

February 27, 2015
Newer reconstruction techniques enabled surgeons to achieve local control and satisfactory long-term survival in patients with pelvic tumors, but the resulting…
Henrik Falconer, MD, PhD In the Journals

Salpingectomy may reduce risk for ovarian cancer

February 27, 2015
Surgical removal of the fallopian tubes may help reduce a woman’s risk for ovarian cancer even if her ovaries are left intact, according to study results.The…
thumbnail for video 4083320513001 Meeting News CoverageVideo

Video: Highlights in cancer and HIV treatments at CROI 2015

February 27, 2015
Infectious Disease News Editorial Board member Paul Volberding, MD, reviews HIV and cancer treatment data presented here at CROI 2015. Highlights include cervical…
More News Headlines »
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
thumbnail for video 4040847621001

MET targeting, PD-L1/PD-1 inhibition highlight recent developments in genitourinary oncology

February 11, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »